Norwegian fund says Novo and Eli Lilly could join trillion-dollar club
A pharmacist displays boxes of Ozempic, an injectable semaglutide drug used to treat type 2 diabetes manufactured by Novo Nordisk,…
health care industry
Neuralink competitor Synchron buys equity stake in the manufacturer
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet…
Advertising giant Publicis pays $350 million to settle US opioid claims
A Publicis Groupe SA sign at its headquarters in Paris, France, Sunday, July 28, 2013. Balint Porneczi | Bloomberg |…
Merck (MRK) 2023 Fourth Quarter Earnings Report
The Merck & Co. logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York…
January was great for stocks: here are our five best-performing companies of the month
Benchmarks hit record highs as stocks advanced during a busy earnings season.
Fourth-quarter earnings set to be best of 2023
Traders work at the New York Stock Exchange (NYSE) in New York City, USA, on February 1, 2024. Brendan McDermid…
Here are Jim Cramer's quick takeaways on 6 stocks in Friday's news
Clorox: The consumer products giant saw a huge increase in profits. It is also recovering from last year's cyberattack. “Things…
Bristol Myers Squibb (BMY) Q4 2023 Earnings Report
Bristol-Myers Squibb reported quarterly earnings and revenue on Friday that beat expectations as its portfolio of new drugs posted strong…
This little-known oncology stock could rise more than 70%, says Citi
Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…
Symptoms of Excessive Screen Time Cost US $73 Billion a Year: Study
American workers spend too much time looking at screens. More than 104 million people in the U.S., including nearly 70%…